Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer

NCT01031446 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: cisplatin
DRUG: everolimus
DRUG: paclitaxel
OTHER: laboratory biomarker analysis

Sponsor

Vanderbilt-Ingram Cancer Center

Collaborators

[object Object]